Clinical trial
Use of Tramadol Injections on the Anaesthetic Success Rate of Intraligamentary Injections in Patients With Symptomatic Irreversible Pulpitis
NCT05538052 is registered in ClinicalTrials.gov with Jamia Millia Islamia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Tramadol Injections on the Anaesthetic Success Rate of Intraligamentary Injections in Patients With Symptomatic Irreversible Pulpitis
- Lead sponsor
- Jamia Millia Islamia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2022
- Completion date
- November 30, 2022
- Enrollment
- 105 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.